http://www.bing.com/news/search?q=amgen&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=amgen&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2ffinance.yahoo.com%2fnews%2famgen-boomerang-cfo-reaps-12-143527606.html&c=14327703543659364264&mkt=en-usThomas Dittrich is the latest “boomerang” executive to return to a former employer as CFO. Over a decade ago he was the biotech company’s chief accountant.Thu, 21 May 2026 15:20:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.Y7MX_zx3P70PadmQfRbAZg&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2famgen-drug-gets-new-warnings-in-japan-after-patient-deaths%2far-AA23Jvxd&c=579172081597520223&mkt=en-usThe Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.Thu, 21 May 2026 03:24:00 GMTThe Wall Street Journal on MSNhttp://www.bing.com/th?id=ONUT.5WhHqU63duWrM_QNs4am4Q&pid=Newsw={0}&h={1}&c=141280854http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2famgens-tavneos-facing-liver-injury-scrutiny-gets-label-update-patient-starts-resume-japan&c=5876359296070350196&mkt=en-usAfter the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once again prescribe Amgen’s rare autoimmune disease med Tavneos (avacopan), albeit ...Thu, 21 May 2026 08:38:00 GMTFierce Pharmahttp://www.bing.com/th?id=ONUT.NPmboq1rNcDJSxcAU8XKsQ&pid=Newsw={0}&h={1}&c=14699500http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.statnews.com%2f2025%2f10%2f20%2famgen-bladder-cancer-bemarituzumab%2f&c=9425937743765445520&mkt=en-usAndrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. BERLIN — In June, Amgen reported ...Sun, 19 Oct 2025 17:01:00 GMTSTAThttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2ffinance.yahoo.com%2fmarkets%2fstocks%2farticles%2flook-amgen-amgn-valuation-tavneos-061554062.html&c=14291339424780548417&mkt=en-usAmgen (AMGN) stock is in focus after safety concerns around its rare disease therapy Tavneos, including reported patient deaths in Japan, prompted regulators and partners to restrict new prescriptions ...Thu, 21 May 2026 23:43:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.gWD2NbdqX9db5YiBgYoN4A&pid=Newsw={0}&h={1}&c=141194432http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2famgen-cfo-griffith-retire-former-finance-vet-returns-fold-galderma&c=16101046970637438999&mkt=en-usAfter some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next year.  | After some six years at the post, Amgen’s finance chief is ...Wed, 20 May 2026 07:04:00 GMTFierce Pharmahttp://www.bing.com/th?id=ONUT.2nqIFirA3HvVdwKOTVb9HA&pid=Newsw={0}&h={1}&c=141280732http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fhuman-resources%2famgen-says-cfo-peter-griffith-to-retire-names-dittrich-as-successor%2far-AA23AJ71&c=9741229940245548475&mkt=en-usMay 19 (Reuters) - Amgen said on Tuesday its chief financial officer, Peter Griffith, would retire, with Thomas Dittrich taking over the role in September. Dittrich, who previously held senior finance ...Tue, 19 May 2026 14:19:57 GMTReuters on MSNhttp://www.bing.com/th?id=ONUT.0SEK0gTFDVQsDIfs109DQA&pid=Newsw={0}&h={1}&c=14800533http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2f20-people-in-japan-died-after-taking-amgen-drug%2far-AA23jhvk&c=5071264463386694957&mkt=en-usKissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new patients.Fri, 15 May 2026 18:11:00 GMTThe Wall Street Journal on MSNhttp://www.bing.com/th?id=ORMS.743c4ccaec715bed1e9a0fd430697436&pid=Newsw={0}&h={1}&c=141280640http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.marketwatch.com%2fstory%2famgen-names-thomas-dittrich-as-finance-chief-fd2ae409&c=3567619022592239134&mkt=en-usAmgen named Thomas Dittrich, a former finance executive at the company, as its next chief financial officer. The biotechnology company said Tuesday that Dittrich will succeed Peter Griffith, who is ...Tue, 19 May 2026 13:56:00 GMTMarketWatchhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.aol.com%2farticles%2fguggenheim-trims-amgen-price-target-145030878.html&c=16965643260884474618&mkt=en-usGuggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN) to $340 from $351 on Monday, May 4, while maintaining a Neutral rating. The revision follows the biotech’s Q1 2026 earnings release and ...Mon, 04 May 2026 14:50:00 GMTAOLhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11e35840f248c5830d9d92c0c302ea&url=https%3a%2f%2fwww.mmm-online.com%2fnews%2fthe-escalator-amgen-cg-life-cosette-pharmaceuticals-and-more%2f&c=3074801229918743117&mkt=en-usCosette Pharmaceuticals named David Bell as chief commercial officer of brands. Heidi Health appointed Jessie Young as president of North America. Wondr Health named Patti Rittling, PhD, CHES as head ...Thu, 21 May 2026 04:50:00 GMTMedical Marketing & Mediahttp://www.bing.com/th?id=ONUT.UXxytK52DNh47H7C5zbixQ&pid=Newsw={0}&h={1}&c=141024683